Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update
Top Cited Papers
- 1 March 2013
- journal article
- practice guideline
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (7), 961-965
- https://doi.org/10.1200/jco.2012.45.9859
Abstract
To provide recommendations on the follow-up and management of patients with breast cancer who have completed primary therapy with curative intent. To update the 2006 guideline of the American Society of Clinical Oncology (ASCO), a systematic review of the literature published from March 2006 through March 2012 was completed using MEDLINE and the Cochrane Collaboration Library. An Update Committee reviewed the evidence to determine whether the recommendations were in need of updating. There were 14 new publications that met inclusion criteria: nine systematic reviews (three included meta-analyses) and five randomized controlled trials. After its review and analysis of the evidence, the Update Committee concluded that no revisions to the existing ASCO recommendations were warranted. Regular history, physical examination, and mammography are recommended for breast cancer follow-up. Physical examinations should be performed every 3 to 6 months for the first 3 years, every 6 to 12 months for years 4 and 5, and annually thereafter. For women who have undergone breast-conserving surgery, a post-treatment mammogram should be obtained 1 year after the initial mammogram and at least 6 months after completion of radiation therapy. Thereafter, unless otherwise indicated, a yearly mammographic evaluation should be performed. The use of complete blood counts, chemistry panels, bone scans, chest radiographs, liver ultrasounds, pelvic ultrasounds, computed tomography scans, [18F]fluorodeoxyglucose–positron emission tomography scans, magnetic resonance imaging, and/or tumor markers (carcinoembryonic antigen, CA 15-3, and CA 27.29) is not recommended for routine follow-up in an otherwise asymptomatic patient with no specific findings on clinical examination.Keywords
This publication has 19 references indexed in Scilit:
- MRI for breast cancer screening, diagnosis, and treatmentThe Lancet, 2011
- An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrenceHealth Technology Assessment, 2011
- Mammographic surveillance in women with a personal history of breast cancer: How accurate? How effective?The Breast, 2010
- A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrenceHealth Technology Assessment, 2010
- Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2008
- Surveillance Mammography following the Treatment of Primary Breast Cancer with Breast Reconstruction: A Systematic ReviewPlastic and Reconstructive Surgery, 2007
- American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant SettingJournal of Clinical Oncology, 2006
- Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation StatementAnnals of Internal Medicine, 2005
- American Society of Clinical Oncology 1998 Update of Recommended Breast Cancer Surveillance GuidelinesJournal of Clinical Oncology, 1999
- Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1997